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A B S T R A C T
Background
Influenza is an infectious virus affecting both humans and animals. In humans, symptoms present as fever, cough, sore throat, runny
nose, headache, muscle and joint pain, and malaise. The epidemiological profile of influenza is influenced by multiple factors, including
transmissibility of the virus and the susceptibility of the population. Annually, influenza is estimated to infect 5% to 10% of adults, with
higher rates in winter seasons in countries with seasonal variation. Exercise could be an intervention to enhance immune response and
limit influenza incidence and its related complications.
Objectives
To assess the efficacy and safety of short and long-term exercise prior to influenza vaccination in enhancing influenza prevention in adults.
Search methods
We searched CENTRAL (2015, Issue 11), which contains the Cochrane Acute Respiratory Infections Group's Specialised Register, MEDLINE
(1966 to 3 November 2015), Embase (1974 to 3 November 2015), CINAHL (1981 to 3 November 2015), LILACS (Latin American and Caribbean
Health Sciences, 1982 to 3 November 2015), PEDro (1980 to 3 November 2015), SPORTDiscus (1985 to 3 November 2015), the WHO Inter-
national Clinical Trials Registry Platform (ICTRP) and ClinicalTrials.gov (November 2015).
Selection criteria
Randomised controlled trials (RCTs) of short- and long-term exercise prior to influenza vaccination for the general adult population were
eligible for inclusion.
Data collection and analysis
Two review authors independently extracted and checked data from the included trials using a standard form. We used the random-effects
model due to differences in the type, duration, intensity and frequency of exercise in the analysis.
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Main results
We included six trials published between 2007 and 2014 that randomised 599 adult participants. Study size ranged from 46 to 158 partici-
pants. Participants were aged between 18 years and 80 years; we could not derive gender proportions, as participants' sex was not report-
ed in all studies. One study was available in abstract form only.
We did not find a significant difference in outcomes between people who exercised and those who did not exercise before receiving in-
fluenza vaccination.
Pre-vaccination exercises included endurance activities such as walking or using a treadmill, and resistance activities included biceps
curls and lateral raises. Five of the studies provided one session of exercise between 25 and 50 minutes. In five studies, exercise was
undertaken on the same day as the vaccination. One study provided exercise over a period of eight weeks before vaccination, with one
2½ hour supervised session, plus daily home exercise practice of 45 minutes. Exercise intensity ranged from 55% to 85% of maximal heart
rate. Control group participants undertook a range of activities, including quiet rest, sitting, reading, meditation or unspecified activity.
One study reported numbers of people who contracted influenza; no significant difference was reported between exercise and no-exercise
participants. None of the included studies reported complications related to influenza illness. Only one study, which we assessed as pro-
viding low-quality evidence, reported numbers of people who experienced adverse events. This study reported no significant difference
in outcomes between people who exercised and those who did not. No studies reported numbers of working days or days lost related to
influenza illness. Only two studies reported participant-centred outcomes.
Overall, study quality was unclear; we assessed five of the six included studies to have at least four unclear 'Risk of bias' domains (allocation
concealment, blinding of outcome assessment, selective reporting and other bias). Insufficient reporting in four studies about selective
reporting did not provide enough information to enable judgement; only two studies were included in trials registers.
Authors' conclusions
From the available evidence, we found that exercising before influenza vaccination is neither beneficial nor harmful. However, study data
were limited and of low quality. Small sample sizes, study design limitations, exercise types, and focus on biochemical rather than partic-
ipant-centred outcomes strongly influenced our findings.
P L A I N   L A N G U A G E   S U M M A R Y
Can exercising before vaccination reduce numbers of adults who get flu or develop complications?
Review question
We looked at whether exercise before influenza (flu) vaccination can decrease numbers of adults who develop flu and reduce complica-
tions.
Background
Exercise can change immune response. Flu is an infectious virus estimated to affect three to five million people worldwide each year.
Seasonal flu vaccination, which acts on the immune system to protect people from infection, is common in many countries.
Search date
We searched the literature up to November 2015.
Study characteristics
We looked at six studies that involved 599 people aged between 18 and 80 years that assessed exercise before flu vaccination. Exercises
included walking or using a treadmill (endurance) and biceps curls and lateral raises (resistance) activities that ranged from 25 to 50
minutes per session. People in five studies did one session of exercise on the day of vaccination; in one study people exercised eight weeks
before vaccination. Exercise was supervised in three studies. People not undertaking exercise (control group) were assessed after periods
of quiet rest.
Study funding sources
Three studies did not report study funding sources; one received support from a drug company that donated flu vaccine, one from a
professional society, and another from government agencies.
Key results
We found no differences in numbers of people who caught flu or developed complications between people who exercised and those
who did not before flu vaccination. Only one study reported how many people developed flu after exercise and vaccination. No studies
reported complications related to flu; only one reported adverse events. None reported numbers of working or other days lost due to flu.
No beneficial differences were reported between exercise and no-exercise groups before vaccination.
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Small numbers of people who were involved in the studies, limitations in study design, and different exercise types meant we were unable
to draw robust conclusions about any benefits of exercise before vaccination. There appears to be no benefit or harm from exercising
before receiving flu vaccination.
Quality of evidence
Evidence quality was very low or low. More robust study designs that include enough people to enable assessment and analysis of findings
may help to determine if exercise before vaccination can reduce numbers of people who develop flu or complications.
Author's conclusions
We found that exercising before influenza vaccination is neither beneficial nor harmful. Small number of people in each included study,
many types of exercises, and focus on blood examination instead of participant-centred outcomes strongly influenced our findings.
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Summary of findings for the main comparison.   Resistance and endurance exercise prior to influenza vaccination versus no exercise prior to influenza
vaccination
Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults
Patient or population: Adults and elderly
Setting: Study laboratory
Intervention: Resistance and endurance exercise
Comparison: no exercise
Anticipated absolute effects*
(95% CI)
Outcomes
Risk of con-
tracting in-
fluenza - no
exercise be-
fore vaccina-
tion
Risk of con-
tracting in-
fluenza - ex-
ercise before
vaccination
Relative effect
(95% CI)
Number of partici-
pants
(studies)
Quality of the
evidence
(GRADE)
Comments
Median risk in study populationIncidence of influenza
Self-reported influenza-like illness
follow-up: adjusted for 1 year
39 per 1000 9 per 1000
(0 to 172)
RR 0.22
(0.01 to 4.40)
98
(1 study)
⊕⊕⊝⊝
very low1,2,3
 
Complications related to influenza illness Not pooled Not pooled Not pooled (no studies)   No events in
either arm
Median risk in study populationAdverse events Hypersensitivity reaction to vacci-
nation
0 per 1000 0 per 1000
(0 to 0)
Not estimable 120
(1 study)
⊕⊕⊝⊝
low1
No events in
either arm
Numbers of working days or days lost related to
influenza illness
Not pooled Not pooled Not pooled (no studies)   No events in
either arm
*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio
GRADE Working Group grades of evidence
High quality: We are very confident that the true effect lies close to that of the estimate of the effect
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Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is sub-
stantially different
Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect
1Limitations in the design and implementation. Risk of selection bias and lack of blinding; allocation concealment not reported.
2Imprecision - wide confidence intervals.
3Indirectness - self-reported influenza-like illness.
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B A C K G R O U N D
Description of the condition
Influenza is an infectious virus affecting both humans and animals.
In humans, symptoms present as fever, cough, sore throat, run-
ny nose, headache, muscle and joint pain, and malaise (CDC 2009;
WHO 2011). There are three types of influenza: strains: A, B and
C. Influenza A has three subtypes of haemagglutinins (H1, H2 and
H3) and two subtypes of neuraminidases (N1 and N2). Influenza B
and C are not subdivided. Influenza A has the ability to make pe-
riodic changes to its strain over time, making efficacious preven-
tion by vaccination a challenge (Demicheli 2014). The epidemiolog-
ical profile of influenza is influenced by several factors, including
transmissibility of the virus and the susceptibility of the population
(CDC 2009; Nair 2011). Influenza is estimated to infect 5% to 10%
of adults, with higher rates in winter seasons in countries with sea-
sonal variation, each year (WHO 2012).
Influenza incidence varies according to age group, with greater risk
observed in children under five years old and adults aged 65 years
or over. Priority groups for influenza vaccination are people with
chronic medical conditions and pregnant women, because these
conditions predispose people to influenza-related illness and hos-
pitalisation (CDC 2010; Molinari 2007).
Influenza is estimated to affect three to five million people world-
wide annually. Economic impact, estimated using a probabilistic
model based on publicly available epidemiological data, is a mean
of USD 87.1 billion per year (Molinari 2007). Costs are predominant-
ly due to medical care, loss of productivity, life-years lost, and death
(CDC 2010; WHO 2012).
Description of the intervention
Regular exercise has a positive impact on health and is considered
a core behavioural strategy for health promotion (Booth 2012). For
this review we defined exercise as "a planned and structured pro-
gramme of motor actions to improve or maintain components of
physical fitness" (Carpersen 1985). Exercise, like administration of
drug therapies, includes components such as frequency, time, type
and intensity (Lobelo 2014). Different types of exercise provoke dif-
ferent physiological responses (Burton 2004; Edwards 2006).
How the intervention might work
Moderate exercise appears to enhance immune function (Edwards
2007) through the induction of a pro-inflammatory environment
in skeletal muscle, particularly during the eccentric phase of mus-
cle contraction (Peake 2005). Proposed benefits include increased
leukocyte numbers, particularly monocytes and dendritic cells
(Tossige-Gomes 2014), enabling enhanced cell migration to the
antigen exposure site (Krüger 2008). Immune transport is further
aided by augmentation of lymph drainage resulting from muscle
contraction (Schillinger 2006). In contrast, intense exercise may
suppress the immune system, causing increased susceptibility to
infection for the first 24 hours after exercise through a negative ef-
fect on neutrophil phagocytic function and a reduction in natural
killer cell and lymphocyte numbers (Kakanis 2010). Moderate-in-
tensity exercise before intramuscular vaccine administration may
therefore improve the initial immune response to vaccination in
comparison to preceding rest or vigorous muscle activity (Pascoe
2014).
Why it is important to do this review
Despite evidence from Cochrane Reviews showing no impact on
hospitalisation or complication rates (Demicheli 2014; Jefferson
2010; Thomas 2013), influenza vaccination is ingrained in many
public health agendas. These reviews demonstrated a moderate
effect from vaccination on symptom reduction and in decreasing
numbers of working days lost through ill health (Demicheli 2014;
Jefferson 2010; Thomas 2013). We aimed to establish if exercise
before vaccination can enhance efficacy by reducing numbers of
sick days and symptoms caused by influenza, and build upon pre-
vious Cochrane Reviews about influenza vaccination. Numbers of
RCTs supporting exercise before influenza vaccination are growing
(Campbell 2010; Edwards 2006; Edwards 2007; Edwards 2010; Ko-
hut 2002; Kohut 2004; Ranadive 2014; Woods 2009).
O B J E C T I V E S
To assess the efficacy and safety of short- and long-term exercise
prior to influenza vaccination to enhance influenza prevention in
adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) investigating exer-
cise before influenza vaccination for the general population. Cross-
over and cluster-RCTs were also eligible for inclusion.
Types of participants
We included participants randomised to exercise or no exercise be-
fore receiving influenza vaccination. We included no studies involv-
ing children aged up to 18 years.
Types of interventions
We included studies that compared exercise before influenza vacci-
nation with participants who did not exercise before influenza vac-
cination. Exercise could be single or multiple sessions, resistance
or aerobic exercise, specific muscle group or whole-body exercise.
Types of outcome measures
Primary outcomes
1. Incidence of influenza (as reported by primary studies).
2. Complications related to influenza illness.
3. Adverse effects of vaccination.
Secondary outcomes
1. Number of working days or days lost related to influenza illness.
2. Blood parameters (IgG, IgM, IL-6, etc.).
Search methods for identification of studies
Electronic searches
We searched the Cochrane Central Register of Controlled Trials
(CENTRAL, 2015, Issue 11), which contains the Cochrane Acute Res-
piratory Infections Group's Specialised Register, MEDLINE (1966 to
3 November 2015), Embase (1974 to 3 November 2015), CINAHL
(1981 to 3 November 2015), LILACS (Latin American and Caribbean
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Health Sciences, 1982 to 3 November 2015), PEDro (Physiotherapy
Evidence Database, 1980 to 3 November 2015) and SPORTDiscus
(1985 to 3 November 2015).
We present MEDLINE and Embase search strategies in Appen-
dix 1 and Appendix 2. We combined the MEDLINE search with
the Cochrane Highly Sensitive Search Strategy for identifying ran-
domised trials in MEDLINE (Lefebvre 2011). We adapted the search
strategy to search the other databases. We did not use language or
publication restrictions. In case of articles in other languages, we
will use academic networks and Cochrane resources to translate
the critical parts to enable screening of abstracts and, if necessary,
critical parts of the full paper.
Searching other resources
We searched the World Health Organization (WHO) Internation-
al Clinical Trials Registry Platform (apps.who.int/trialsearch/) and
ClinicalTrials.gov for completed and ongoing studies to 3 Novem-
ber 2015. We checked the reference lists of all primary studies and
review articles for additional references. We did not email experts in
the field about other published and unpublished studies that may
be eligible for inclusion.
Data collection and analysis
Selection of studies
Two review authors independently screened all titles and abstracts
identified from searches to determine which met the inclusion cri-
teria. We retrieved potentially relevant papers in full text. The same
review authors independently screened full-text articles for inclu-
sion or exclusion, with discrepancies resolved by discussion and by
consulting a third review author where necessary to reach consen-
sus. We planned to present reports of included studies. All excluded
studies, with reasons for exclusion, are presented in Characteristics
of excluded studies. The study screening and selection process is
presented in Figure 1.
Data extraction and management
Two review authors independently extracted data from the includ-
ed studies using a standard data extraction form. We resolved
any discrepancies by discussion until we reached consensus, or
through consultation with a third review author where necessary.
Two review authors extracted data for blood parameters from fig-
ures in four studies (Edwards 2007; Edwards 2010; Long 2012;
Ranadive 2014) to measure the mean and standard errors for analy-
sis and comparison (Silva 2012).
Assessment of risk of bias in included studies
Two review authors independently assessed risk of bias for each in-
cluded study using the 'Risk of bias' tool published in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011a). A
third review author resolved any disagreements by discussion. We
assessed risk of bias according to the following domains.
1. Random sequence generation (selection bias). We classified
studies as low risk of bias if they properly described how the ran-
dom sequence was generated. We classified them as unclear risk
of bias if they did not provide enough information to be judged,
and as high risk of bias if the randomisation was conducted in a
predictable way.
2. Allocation concealment (selection bias). We classified the stud-
ies as low risk of bias if they properly described how the alloca-
tion was concealed. We classified them as unclear risk of bias if
they did not provide enough information to be judged, and as
high risk of bias if the allocation was predictable.
3. Blinding of participants and personnel (performance bias). Due
to the characteristics of the intervention (exercise), the partici-
pants could not be blinded.
4. Blinding of outcome assessment (detection bias): Due to the
characteristics of the intervention (exercise), the participants
could not be blinded; however, they could be blinded to the in-
jection, control group with no vaccine inside.
5. Incomplete outcome data (attrition bias). We classified the stud-
ies as low risk of bias if they properly described data losses or in-
complete data and provided reasons. We classified them as un-
clear risk of bias if they did not provide enough information to
be judged. If the studies excluded or omitted analyses of data
outcomes we considered them as high risk of bias.
6. Selective reporting (reporting bias). We classified the studies as
low risk of bias if they properly described what they planned
to do in their project and published all the outcomes planned.
We classified them as unclear risk of bias if they did not provide
enough information to be judged. If the studies reported only
statistically significant findings rather than show the complete
results we considered them high risk of bias.
7. Other bias (other potential sources of bias) related to particular
trial design (cross-over and cluster-randomised) or specific cir-
cumstances such as adjustment of prognostic factors (e.g. base-
line exercise habits, physical fitness).
Measures of treatment e=ect
Types of measurement of treatment effects that were analysed in-
cluded:
1. Dichotomous data: we used risk ratio (RR) for the binary out-
comes: complications arising from influenza-related illness, ad-
verse effects of vaccination, and adherence to the group inter-
vention.
2. Continuous data: we combined results using the mean differ-
ence (MD) for measures that used the same scale, or the stan-
dardised mean difference (SMD) where different scales had been
used to evaluate the same outcome for blood parameters (anti-
body titres).
3. Rate: we did not use rate ratio to compare rates between groups
for number of influenza episodes, due to lack of reported stud-
ies.
Unit of analysis issues
We considered individual participants as the unit of analysis.
Among the six included studies, we included one cross-over RCT
and considered only the phase before crossing over interventions.
If cluster-RCTs had been included, we would have made the neces-
sary statistical adjustments for clustering participants.
Dealing with missing data
We did not attempt to contact study authors because we found no
inconsistencies between randomised and analysed study partici-
pants.
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Assessment of heterogeneity
We assessed the inconsistencies between studies using the I2 sta-
tistic and described the percentage of variability in effect. We con-
sidered heterogeneity substantial if I2 statistic was over 50%.
Assessment of reporting biases
We identified no mismatches between study protocols and reports.
We had planned to assess the impact of including such studies by
conducting a sensitivity analysis. We did not perform a funnel plot
asymmetry test, as we only included six trials.
Data synthesis
Meta-analysis of the included RCTs was possible only for partici-
pants' blood parameters. We used a random-effects model, inde-
pendently of the heterogeneity identified. When it was not possible
to pool data, we present narrative analyses of individual studies.
GRADE and 'Summary of findings' table
We created a 'Summary of findings' table using the following out-
comes: incidence of influenza, complications related to influen-
za illness, adverse events, and numbers of working days or days
lost related to influenza illness. We used the five GRADE considera-
tions (Atkins 2004): study limitations, consistency of effect, impre-
cision, indirectness and publication bias, to assess the quality of a
body of evidence as it relates to the studies which contribute da-
ta to the meta-analyses for the prespecified outcomes. We used
methods and recommendations described in Section 8.5 and Chap-
ter 12 of the Cochrane Handbook for Systematic Reviews of Inter-
ventions (Higgins 2011b), using GRADEproGDT software (GRADE-
proGDT 2015). We justified all decisions to down- or upgrade the
quality of studies using footnotes, and we made comments to aid
readers' understanding of the review where necessary.
Subgroup analysis and investigation of heterogeneity
We conducted subset analyses for blood parameters antibody titre:
1. follow-up over time;
2. timing of vaccination; and
3. type of exercise.
Sensitivity analysis
We pooled studies to verify if the impact of risk of bias affected the
overall treatment effect of exercising. We also assessed which stud-
ies contributed to heterogeneity.
R E S U L T S
Description of studies
Results of the search
Our search identified 485 records from databases, handsearches of
reference lists, grey literature and trial register search results. We
removed 68 duplicate records (n = 317 records). Two review authors
then assessed titles and abstracts and deleted 305 records that did
not match inclusion criteria. We obtained full-text copies of the re-
maining 12 potentially relevant references. Of these, six studies did
not meet inclusion criteria. See Figure 1.
 
Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
8
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Figure 1.   Study flow diagram
 
Included studies
We included six trials that randomised 599 adult participants, pub-
lished between 2007 and 2014 in English language (Edwards 2007;
Edwards 2010; Edwards 2013; Hayney 2014; Long 2012; Ranadive
2014). Edwards 2013 was available as an abstract only. (See Includ-
ed studies; Table 1; Table 2).
Design
Five included studies were parallel RCTs (Edwards 2007; Edwards
2010; Edwards 2013; Hayney 2014; Long 2012); Ranadive 2014 was
a randomised, cross-over design.
Sample sizes
The included studies randomised 599 adult participants. Sample
size ranged from 46 participants (Edwards 2013) to 158 participants
(Edwards 2010).
Setting
All included trials were single-centre studies: two were conducted
in the USA (Hayney 2014; Ranadive 2014) and four in the UK (Ed-
wards 2007; Edwards 2010; Edwards 2013; Long 2012).
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Participants
Participants were aged from 18 years to 80 years. Proportions of
women ranged from 50% to 82%. One study did not report partici-
pants' gender (Long 2012).
Interventions
Pre-vaccination exercises included endurance activities such as
walking or using a treadmill, and resistance activities including bi-
ceps curls and lateral raises. Five studies included one exercise ses-
sion of between 25 minutes and 50 minutes on the same day as
the vaccination (Edwards 2007; Edwards 2010; Edwards 2013; Long
2012; Ranadive 2014). Hayney 2014 provided exercise over a peri-
od of eight weeks before vaccination, with one 2½-hour supervised
session, plus daily home exercise practice of 45 minutes. Exercise
intensity ranged from 55% to 85% of maximal heart rate. Control
group participants undertook a range of activities including quiet
rest, sitting, reading or no exercise.
Outcomes
Hayney 2014 reported numbers of people who contracted influen-
za; no significant difference was reported between exercise and no-
exercise participants. None of the included studies reported com-
plications related to influenza illness.
Long 2012 reported numbers of people who experienced adverse
events. This study reported no significant difference in outcomes
between people who exercised and those who did not.
No studies reported numbers of working days or days lost related
to influenza illness.
Excluded studies
We excluded six studies. Of these, four were not RCTs, and two did
not match our inclusion criteria because control group participants
also undertook exercise (see Characteristics of excluded studies).
Risk of bias in included studies
Figure 2 and Figure 3 are graphic presentations of risk of bias' as-
sessments. The overall quality of the studies was unclear, since
five of the six included studies had at least four unclear risk of
bias domains (allocation concealment, blinding of outcome assess-
ment, selective reporting and other bias). Insufficient information
in four studies about selective reporting did not allow judgement
(Edwards 2007; Edwards 2010; Edwards 2013; Ranadive 2014), as
only two studies were included in trials registers (Hayney 2014;
Long 2012).
 
Figure 2.   Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies
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Figure 3.   Risk of bias summary: review authors' judgements about each risk of bias item for each included study
 
Allocation
Three studies appropriately described randomisation procedures
(Edwards 2007; Edwards 2013; Hayney 2014), two studies did not
provide sufficient information to enable assessment (Long 2012;
Ranadive 2014), and one study was classified as high risk of bias:
"Participants were pseudo-randomised, maintaining an even sex
distribution" (Edwards 2010). For allocation concealment, we clas-
sified five studies as unclear risk of bias since they did not provide
sufficient information to enable assessment. We assessed only one
study at low risk of bias, because investigators used codes provided
in concealed envelopes, which were opened after consent to indi-
cate allocation (Hayney 2014).
Blinding
We considered five studies at high risk of bias for blinding par-
ticipants and personnel, since the nature of the study interven-
tions (exercise) meant that blinding of participants was not possi-
ble. However, Ranadive 2014 was considered low risk of bias be-
cause personnel were blinded by using sham vaccination. Consid-
ering detection bias and blinding of outcome assessment, five stud-
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ies did not provide sufficient information to enable assessment;
Hayney 2014 blinded laboratory staC performing the haemaggluti-
nation inhibition assay (HIA) to participant status. Only one study
used a placebo vaccination.
Incomplete outcome data
We classified five studies (Edwards 2007; Edwards 2010; Hayney
2014; Long 2012; Ranadive 2014) at low risk of bias, since losses to
follow-up were less than 10% for the antibody titre analysed in each
study; these studies also provided adequate data analysis in rela-
tion to losses to follow-up. We rated one study at unclear risk of bias
because of insufficient information to enable judgement about ex-
clusions, and no reporting of missing data. This study was available
in abstract form only (Edwards 2013).
Selective reporting
Only two studies registered their trials before conducting the study.
We found no differences between the protocols and the study re-
ports, and classified both at low risk of bias (Hayney 2014; Long
2012). We classified the remaining four included studies at unclear
risk of bias, because of insufficient information to enable outcome
assessment (antibody titre) from different timepoints or analysis
across study follow-up.
Other potential sources of bias
We considered one study to be at high risk of bias due to baseline
imbalance of older people, either sedentary or physically active,
since the authors did not control for physical activity level in the
analysis (Ranadive 2014).
Three studies did not report study funding sources; one received
support from a drug company that donated flu vaccine, one from a
professional society, and another from government agencies.
E=ects of interventions
See: Summary of findings for the main comparison Resistance
and endurance exercise prior to influenza vaccination versus no ex-
ercise prior to influenza vaccination
Incidence of influenza
Hayney 2014 reported no significant difference between exercise
and non-exercise groups in relation to influenza incidence (risk ra-
tio (RR) 0.22, 95% confidence interval (CI) 0.01 to 4.40, participants
= 98). We rated the evidence quality as very low (Summary of find-
ings for the main comparison).
Complications related to influenza illness
None of the included studies reported data about complications re-
lating to influenza.
Adverse events associated with vaccination
Long 2012 (120 participants) reported adverse events associated
with vaccination; none were reported in the influenza vaccination
and non-vaccination groups. We assessed evidence quality as low
(Summary of findings for the main comparison).
Numbers of working days or days lost related to influenza
illness
None of the included studies reported data on numbers of working
days or days lost related to influenza illness.
Blood parameters
Five studies reported blood parameters (Edwards 2007; Edwards
2010; Hayney 2014; Long 2012; Ranadive 2014). We conducted sub-
set analyses for antibody titres of viral strains A and B for follow-up
over time (Analysis 1.1), vaccination timing (Analysis 1.2) and exer-
cise type (Analysis 1.3). We assessed the evidence quality as low due
to lack of information about study design and implementation (risk
of selection bias and lack of blinding, allocation concealment) not
being adequately reported in most studies; we also found impreci-
sion, indicated by wide confidence intervals.
Antibody titre - follow-up over time
Up to six weeks follow-up aLer vaccination
We found no significant difference between exercise and no-exer-
cise study arm participants (five studies, 490 participants; strain
A: standardised mean difference (SMD) -0.05, 95% CI -0.28 to 0.18,
Analysis 1.1.1; Chi2 test 5.97; df = 4; P = 0.20; I2 statistic 33%. Strain
B: SMD -0.11, 95% CI -0.29 to 0.08, Analysis 1.1.2; Tau2 = 0.00, Chi2
test 0.88, df = 4, P = 0.93; I2 statistic 0%).
Over 6 weeks follow-up aLer vaccination
We found no significant difference between exercise and no-exer-
cise participants (two studies, 155 participants; strain A: SMD 0.09,
95% CI -0.23 to 0.41, Analysis 1.1.3; Tau2 = 0.00; Chi2 test 0.04, df =
1, P = 0.83, I2 statistic 0%. strain B: SMD -0.23, 95% CI -0.70 to 0.25,
Analysis 1.1.4; Tau2 = 0.06; Chi2 test 2.00, df = 1, P = 0.16, I2 statistic
50%).
Antibody titre - vaccination timing
Five studies contributed data to this outcome. We analysed data in
six subsets (Analysis 1.2).
Antibody titres viral strains A and B - Exercise immediately prior to
vaccination - up to six weeks follow-up
We found no significant difference between exercise and no-exer-
cise study arm participants (four studies, 392 participants; strain A:
SMD -0.14, 95% CI -0.35 to 0.07; Analysis 1.2.1; Tau2 = 0.00; Chi2 test
2.70, df = 3, P = 0.44, I2 statistic 0%. Strain B: SMD -0.14, 95% CI -0.36
to 0.07; Analysis 1.2.2; Tau2 = 0.00; Chi2 test 0.39, df = 3, P = 0.94, I2
statistic 0%).
Antibody titres viral strains A and B - Exercise immediately prior to
vaccination - over six weeks follow-up
We found no significant difference between exercise and no-exer-
cise study arm participants (one study, 57 participants; strain A:
SMD 0.14, 95% CI -0.41 to 0.68; Analysis 1.2.3. Strain B: SMD -0.51,
95% CI -1.07 to 0.04; Analysis 1.2.4).
Antibody titres viral strains A and B - Vaccination aLer six weeks of
exercise
We found no significant difference between exercise and no-exer-
cise study arm participants (one study, 98 participants; strain A:
SMD 0.06, 95% CI -0.33 to 0.46; Analysis 1.2.5. Strain B: SMD -0.02,
95% CI -0.42 to 0.37; Analysis 1.2.6).
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Antibody titre - exercise type
We identified five relevant studies and categorised data into eight
subsets (Analysis 1.3).
Antibody titres viral strains A and B - Resistance exercise prior to
vaccination - up to six weeks follow-up
We found no significant difference between exercise and no-exer-
cise study arm participants (two studies, 217 participants; strain A:
SMD 0.01, 95% CI -0.29 to 0.31, Analysis 1.3.1; Tau2 = 0.00; Chi2 test
0.87, df = 1, P = 0.35, I2 statistic 0%. Strain B: SMD -0.08, 95% CI -0.38
to 0.22, Analysis 1.3.2; Tau2 = 0.00; Chi2 test 0.05, df = 1, P value 0.82,
I2 statistic 0%).
Antibody titres viral strains A and B - Endurance exercise prior to
vaccination - up to six weeks follow-up
We found no significant difference between exercise and no-exer-
cise study arm participants (two studies, 175 participants; strain A:
SMD -0.28, 95% CI -0.58 to 0.02, Analysis 1.3.3; Tau2 = 0.00; Chi2 test
0.02, df = 1, P = 0.89, I2 statistic 0%. Strain B: SMD -0.21, 95% CI -0.50
to 0.09, Analysis 1.3.4; Tau2 = 0.00; Chi2 test 0.01, df = 1, P = 0.94, I2
statistic 0%).
Antibody titres viral strains A and B - Resistance exercise immediately
prior to vaccination - over six weeks follow-up
We found no significant difference between exercise and no-exer-
cise study arm participants (one study, 57 participants; strain A:
SMD 0.14, 95% CI -0.41 to 0.68, Analysis 1.3.5. Strain B: SMD -0.51,
95% CI -1.07 to 0.04, Analysis 1.3.6).
Antibody titres viral strains A and B - Endurance exercise for eight
weeks then vaccination
We found no significant difference between exercise and no-exer-
cise study arm participants (one study, 98 participants; strain A:
SMD 0.06, 95% CI -0.33 to 0.46, Analysis 1.3.7. Strain B: SMD -0.02,
95% CI -0.42 to 0.37, Analysis 1.3.8).
D I S C U S S I O N
Summary of main results
We aimed to assess the efficacy and safety of short- and long-term
exercise prior to influenza vaccination to enhance influenza pre-
vention in adults.
We did not find significant differences for any outcomes between
people who exercised and those who did not before influenza vac-
cination. Only one study reported influenza incidence; none inves-
tigated complications related to influenza illness; and one study re-
ported adverse events. No included studies investigated numbers
of working days or days lost related to influenza; five studies report-
ed blood parameter data. We reported data for several subsets: an-
tibody titre follow-up over time and according to exercise type. We
pooled effects of antibody titre post-intervention. Only two studies
reported participant-centred outcomes; all studies planned to in-
vestigate blood parameters to identify immunological reasoning to
support the use of exercise prior to influenza vaccination. Overall,
we assessed study quality as low.
We analysed findings from six RCTs that compared exercise versus
no exercise before and immediately before influenza vaccination
and found:
• Influenza incidence was slightly lower in the exercise group;
however, data came from only one study assessed as providing
very low-quality evidence.• No adverse events were reported for either exercise or no-ex-
ercise participant groups; however, data came from only one
study assessed as providing low-quality evidence.• The standardised mean difference (SMD) in the intervention
group for blood parameters was 0.05 units lower (range -0.28 to
+0.18) in serum antibody titres of viral strain A. Data for this out-
come came from five studies.• The SMD in the intervention group for blood parameters was
0.11 units lower (range -0.29 to +0.08) in serum antibody titres of
viral strain B. Data for this outcome came from five studies.
Overall completeness and applicability of evidence
We found that exercise before influenza vaccination did not im-
prove protection provided by influenza vaccination. We assessed
the current evidence as low quality, due to imprecision and high
risk of bias. Given the small body of evidence, and the relative nov-
elty of the concept that exercise before vaccination could influence
outcomes, it may be too soon to draw further conclusions. Differ-
ent types of exercise and intensity of physical effort were not widely
considered by the included studies and may confer different phys-
iological adaptations, either beneficial or harmful.
It is also important to highlight that study data were limited in
terms of numbers of outcomes reported; most did not assess par-
ticipant-centred outcomes. Most studies investigated immunolog-
ical outcomes to assess the hypothesis that exercise can improve
efficacy and reduce complications related to influenza vaccination.
The applicability of evidence to clinical practice remains uncertain.
Quality of the evidence
The overall quality of evidence was low. We based this assessment
on lack of blinding and risk of selection bias (allocation conceal-
ment not reported in the studies), and imprecision, with small sam-
ple sizes and wide confidence intervals. We found a high risk of bias
for blinding of participants and personnel, and reporting deficits in
at least four domains for five of the six included studies.
Randomisation sequence generation was not clearly described in
Long 2012 and Edwards 2013; these studies applied pseudo-ran-
domisation.
The nature of the exercise interventions investigated meant that it
was not possible to blind participants. Sham vaccination was used
in Ranadive 2014. While outcome assessors could be blinded, only
Hayney 2014 provided sufficient information to confirm that blind-
ing was carried out. Attrition bias was not a concern in most studies;
only Edwards 2013 was unclear regarding this domain, although
only Long 2012 and Ranadive 2014 provided appropriate methods
(e.g. intention-to-treat analysis) for dealing with missing data and
dropouts. Four studies were not listed in trials registers (Edwards
2007; Edwards 2010; Edwards 2013; Ranadive 2014).
Potential biases in the review process
We followed recommendations made for study selection, data col-
lection, and data analysis provided in the Cochrane Handbook for
Systematic Reviews of Interventions in this review (Higgins 2011b).
The strengths of the review process were numbers of databases
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searched and search sensitivity to detect all potentially relevant
studies.
Review limitations were that too few studies were included to as-
sess for publication bias by constructing funnel plots; poor study
reporting meant that we could not assess some 'Risk of bias' do-
mains; and we found an absence of participant-centred outcome
data in the included RCTs.
Agreements and disagreements with other studies or
reviews
Pascoe 2014 conducted a systematic review about vaccination pro-
grammes for influenza, meningococcus, tetanus, keyhole limpet
haemocyanin (KLH) and pneumococcus to observe the effects of
exercise on immune response prior to vaccination. The authors
included 20 studies that applied RCT, cross-sectional and obser-
vational study designs. The evidence presented by Pascoe 2014
showed that exercise significantly improved immune response to
vaccination. The authors used the "Assessing methodological qual-
ity of systematic review reviews (AMSTAR)" instrument to assess
data quality (good quality, 8 out of a possible 11 points). Howev-
er, there were some limitations in Pascoe 2014: the quality of the
included studies was not assessed and documented; the scientific
quality of the included studies was not appropriately applied in for-
mulating conclusions; results were not pooled for assessment.
Our review focused on exercise before influenza vaccination, and
we have improved on the work presented by Pascoe 2014. We re-
ported synthesis and assessment of the evidence, documented as-
sessment of study quality, and provided conclusions based on our
findings.
We found no differences in benefits or harms from exercise before
influenza vaccination. A possible reason could be that the includ-
ed studies did not adjust for baseline characteristics according to
the physical activity levels of each participant, so that the dose-re-
sponse of exercising before influenza vaccination could have been
diluted in the results.
Analysis of the published evidence about exercise before influenza
vaccination demonstrated that exercise in its many types and in-
tensities did not provide either additional benefit or harm before
influenza vaccination.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
We were unable to determine if exercise before influenza vaccina-
tion is effective for reducing influenza incidence, complications re-
lated to influenza illness, adverse events or blood parameter out-
comes. We rated the quality of the evidence as low or very low;
there is significant uncertainty around benefits or harms of exercise
before influenza vaccination.
Implications for research
The biological plausibility of how exercise functions influence
health outcomes remains unclear, and exercise mechanisms
should be further explored. Exercise type, intensity, duration and
frequency are challenging to estimate to derive beneficial levels
before influenza vaccination. We suggest that researchers design-
ing future studies should investigate participant-focused outcomes
such as influenza incidence, complications related to influenza ill-
ness, and adverse events. It is also essential to adequately describe
and report study design, results and outcomes that are relevant to
public health objectives and agendas.
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Methods AIMS AND OBJECTIVES To compare the effects of eccentric exercise on the immune response in men
and women
STUDY DESIGN Parallel RCT
DATES OF STUDY IMPLEMENTATION from December 2004 to an unspecified date
STUDY DURATION 20 weeks
SETTING, NUMBER OF CENTRES University of Birmingham, UK; single centre
Participants INCLUSION CRITERIA Physically active students
EXCLUSION CRITERIA
"None of the participants had received the influenza vaccine in the past year, or reported influenza in
the winter prior to participation. None of the participants smoked, had a history of immune or cardio-
vascular disease, were suffering from an acute infection or illness, were pregnant, were currently taking
medication (except birth control), or had a history of vaccine-related allergies or side-effects. All par-
ticipants were instructed to abstain from vigorous exercise for at least 24 hours, alcohol for at least 12
hours, caffeine for at least 2 hours, and food for at least 1 hour prior to testing. In addition, none of the
participants had performed any regular resistance training in the past 6 months."
RECRUITMENT
N SCREENED 60 students N RANDOMISED 60 students N COMPLETED 57 students
N INTERVENTION GROUP 40 students N CONTROL GROUP 20 students
GENDER 29 men; 31 women
AGE Men = 20.1 years (SD 1.64 years); Women = 20.6 years (SD 2.55 years)
Interventions DESCRIPTION OF INTERVENTION
"Eccentric portions of the biceps curl and lateral raise exercises, contracting the biceps brachii and del-
toid muscles of the non-dominant arm. The weights used were 85% of each participant’s single repeti-
tion concentric maxima which had been determined 1 week earlier. All participants performed 50 rep-
etitions of each contraction (6 sets of 7 repetitions followed by 2 sets of 4 repetitions). They completed
a set of lateral raises, rested 30 seconds, completed a set of biceps curls, and rested 60 seconds before
the next set of lateral raises. The task lasted approximately 25 min."
DELIVERY An investigator tracked each movement
COMPARATOR GROUP Remained resting quietly, reading for 25 minutes
Edwards 2007 
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CO-INTERVENTIONS None
Outcomes PRESPECIFIED OUTCOME MEASURES Blood samples, haemagglutination inhibition test, cell-mediat-
ed antigen-specific immunity, limb circumference and pain, stress
DETAILS OF ALL GROUPS
Exercise group: allocated n = 40, analysed at 6 weeks n = 38, analysed at 8 weeks n = 35, analysed at 20
weeks n = 37
Control group: allocated n = 20, analysed at 6 weeks n = 19, analysed at 8 weeks n = 19, analysed at 20
weeks n = 20
FOLLOW-UP PERIOD 6 week, 8 week and 20 week points
Notes TRIAL REGISTRATION Not registered
ETHICS All participants gave written informed consent and the study was approved by the South Birm-
ingham Local Research Ethics Committee
FUNDING Influenza vaccines donated by GlaxoSmithKline, UK
CONFLICTS OF INTEREST Not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "Participants were allocated on a 2:1 ratio to either the exercise (N = 40) or
control (N = 20) groups, based on a pre-determined restricted random assign-
ment to force an unequal sample size schedule"
Allocation concealment
(selection bias)
Unclear risk No information provided. We assumed that participants and investigators
could not foresee assignment prior to allocation
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk Participants were not blind to exercise or control
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk No information provided
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 7.5% dropout in the exercise group. No intention-to-treat used
Selective reporting (re-
porting bias)
Unclear risk Outcomes proposed in the Methods are reported in the results. However,
study protocol was not registered
Other bias Low risk None found
Edwards 2007  (Continued)
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"To investigate whether exercise augmented the immune response to a reduced dose vaccine, and
whether the intensity of exercise influenced the efficacy of the intervention."
"To compare the efficacy of a relatively low (60% of concentric one repetition maximum (1 RM)), medi-
um (85% 1 RM), and high (110% 1 RM) intensity eccentric exercise intervention"
STUDY DESIGN RCT
DATES OF STUDY IMPLEMENTATION Not known
STUDY DURATION 28 days
SETTING, NUMBER OF CENTRES University of Birmingham, UK. Single centre
Participants INCLUSION CRITERIA Not reported
EXCLUSION CRITERIA
"Smoking, a history of immune or cardiovascular disease, current acute infection or illness, pregnan-
cy or suspected pregnancy, and a history of vaccine-related allergies or side effects. Use of prescription
medication within 1 month of participation was also an important exclusion criterion; but females tak-
ing the contraceptive pill were not excluded. In addition, none of the participants reported having per-
formed any resistance training in the 6 months prior to testing."
RECRUITMENT
N SCREENED 160 participants N RANDOMISED 158 participants N COMPLETED 158 participants
INTERVENTION A 40 studentsINTERVENTION B 40 studentsINTERVENTION C 40 studentsCONTROL
40 students
GENDER (completed study) 78 men; 80 women
AGE 20.5 ± 1.6 years
Interventions DESCRIPTION OF INTERVENTION
"Eccentric portions of the biceps curl and lateral raise exercises, contracting the biceps brachii and del-
toid muscles of the non-dominant arm. The weights used were 85% of each participant’s single repeti-
tion concentric maxima which had been determined 1 week earlier. All participants performed 50 rep-
etitions of each contraction (6 sets of 7 repetitions followed by 2 sets of 4 repetitions). They completed
a set of lateral raises, rested 30 seconds, completed a set of biceps curls, and rested 60 seconds before
the next set of lateral raises. The task lasted approximately 25 minutes."
DELIVERY An investigator tracked each movement
CONTROL GROUP Quiet rest for 25 minutes
CO-INTERVENTIONS None
Outcomes PRESPECIFIED OUTCOME MEASURES
Blood samples, haemagglutination inhibition test, cell-mediated antigen-specific immunity, limb cir-
cumference, pain, stress, CK and IL-6
GROUP ALLOCATION
Exercise group 60% of the concentric one repetition maxima (1RM): allocated n = 40, analysed at 28
days n = 40
Exercise group 85% of the concentric one repetition maxima (1RM): allocated n = 40, analysed at 28
days n = 40
Exercise group 110% of the concentric one repetition maxima (1RM): allocated n = 40, analysed at 28
days n = 39
Edwards 2010  (Continued)
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Control group: allocated n = 40, analysed at 28 days n = 39, analysed at 8 weeks n = 19, analysed at 20
week n = 20
FOLLOW-UP PERIOD 28 days
Notes TRIAL REGISTRATION No registry
ETHICS Participants provided written informed consent; study protocol approved by the Black Country
Local Research Ethics Committee
FUNDING Not reported
CONFLICTS OF INTEREST Not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk "Participants were pseudo-randomised, maintaining an even sex distribution"
Allocation concealment
(selection bias)
Unclear risk No information provided
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk Participants were not blind to exercise or control
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk No information provided
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 1% dropout
Selective reporting (re-
porting bias)
Unclear risk The outcomes proposed in the Methods were reported in the Results. Howev-
er, study protocol was not registered
Other bias Low risk None found
Edwards 2010  (Continued)
 
 
Methods CONFERENCE ABSTRACT
AIMS AND OBJECTIVES "To investigate the effects of exercise immediately prior to influenza vaccina-
tion on immune responses"
STUDY DESIGN Parallel RCT
DATES OF STUDY IMPLEMENTATION Not known
STUDY DURATION 1 month
SETTING, NUMBER OF CENTRES Not reported
Participants INCLUSION CRITERIA Not reported
Edwards 2013 
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EXCLUSION CRITERIA Not reported
RECRUITMENT
N SCREENED 46 participants N RANDOMISED 46 participants N COMPLETED 46 participants
GENDER 23 men; 23 women
AGE Mean age = 73 ± 7 years
Interventions DESCRIPTION OF INTERVENTION
The exercise group performed 50 mins of resistance exercises using upper and lower body muscle
groups at an intensity of 60% of predetermined 1 repetition maximum (1RM)
DELIVERY Not reported
COMPARATOR GROUP Quiet reading
CO-INTERVENTIONS None
Outcomes PRESPECIFIED OUTCOME MEASURES Changes in inflammatory markers
GROUP ALLOCATION
Exercise group: allocated n = 23, analysed at 1 month not reported
Control group: allocated n = 23, analysed at 1 month not reported
FOLLOW-UP PERIOD 1 month
Notes TRIAL REGISTRATION Not reported
ETHICS Not reported
FUNDING Not reported
CONFLICTS OF INTEREST Not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "Randomly assigned to complete a control (quiet reading) or exercise task..."
Allocation concealment
(selection bias)
Unclear risk No information provided
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk Participants were not blind to exercise or control
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk No information provided
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk No information provided
Edwards 2013  (Continued)
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Selective reporting (re-
porting bias)
Unclear risk No study protocol was registered
Other bias Low risk None found
Edwards 2013  (Continued)
 
 
Methods AIMS AND OBJECTIVES To compare influenza vaccine responses due to meditation or exercise training
with controls
STUDY DESIGN Parallel RCT
DATES OF STUDY IMPLEMENTATION June 2012 to June 2016
STUDY DURATION 20 weeks
SETTING, NUMBER OF CENTRES University of Wisconsin Health Sports Medicine Center; single centre
Participants INCLUSION CRITERIA Participants aged 50 years or older, willing to undertake any of the 3 randomi-
sation outcomes, and reporting either 2 or more colds in the last 12 months or an average of 1 or more
colds per year
EXCLUSION CRITERIA "...previous training or current practice of meditation, moderate exercise at
least 2 times a week or vigorous exercise at least 1 time a week, and a score of less than 24 points on
the Folstein Mini-Mental State Examination or more than 14 points on the 9-item Patient Health Ques-
tionnaire (PHQ-9) depression screen; immunodeficiency, autoimmune, or malignant disease; or prior
allergic reaction to influenza vaccine or egg allergy."
RECRUITMENT
N RANDOMISED 154 participants N COMPLETED 149 participants
GENDER 21 men, 133 women
AGE Mean age 59.26 ± 8.87 years
Interventions DESCRIPTION OF INTERVENTION "The exercise program was designed and led by exercise physiolo-
gist at was matched to the meditation program in terms of duration (8 weeks), contact time (weekly 2.5
hour group sessions), home practice (45 min per day), and location. Borg’s Rating of Perceived Exertion
was used to guide participants toward moderate intensity, sustained exercise, with a target rating of 12
to 16 points on the 6-to-20 point scale."
DELIVERY Senior exercise physiology staC
CONTROL GROUP Wait-list control
Outcomes PRESPECIFIED OUTCOME MEASURES Influenza antibody responses post-immunisation; Seroprotec-
tion at least 160 HA U and measures of well-being
GROUP ALLOCATION Exercise: 47 participants; Meditation: 51 participants; Control: 51 participants
FOLLOW-UP PERIOD 3 months
Notes TRIAL REGISTRATION NCT01057771
ETHICS Not reported
FUNDING Supported by a grant from the National Institutes of Health (NIH), National Center for Com-
plementary and Alternative Medicine (1R01AT004313); and by a grant UL1RR025011 from the Clinical
and Translational Science Award (CTSA) Program of the National Center for Research Resources, Na-
Hayney 2014 
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tional Institutes of Health. Aleksandra Zgierska is supported by grant K23 AA017508 from National Insti-
tute on Alcohol Abuse and Alcoholism at NIH
CONFLICTS OF INTEREST Bruce Barrett was previously supported by career development grants from
the National Center for Complementary and Alternative Medicine (K23AT00051) and from the Robert
Wood Johnson Foundation, both of which were essential for developing the methodology and infra-
structure for recruiting and monitoring research subjects, and for assessing their acute respiratory in-
fections
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "SAS software was used to generate 165 unique identification numbers in bal-
anced blocks of 3"
Allocation concealment
(selection bias)
Low risk "Codes were concealed envelopes, which were opened after consent to indi-
cate allocation"
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk Participants were not blind to exercise or control
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk "The laboratory staC performing the HIA used the standard micro titre tech-
niques and was blinded to participant status"
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 3% dropout
Selective reporting (re-
porting bias)
Low risk Outcomes proposed in the protocol were included in published results
Other bias Low risk None found
Hayney 2014  (Continued)
 
 
Methods AIMS AND OBJECTIVES To compare the responses of a young and older participant cohort to deter-
mine if the efficacy of this intervention differs between the age groups
STUDY DESIGN Parallel RCT
DATES OF STUDY IMPLEMENTATION Not known
STUDY DURATION 1 month
SETTING, NUMBER OF CENTRES University of Birmingham, UK and the West Midlands area. Centre/s
not specified
Participants INCLUSION CRITERIA "Either 18–30 or 50–64 years old; not highly endurance trained; no vaccination
against influenza in the previous year or pneumonia in the last 10 years; no allergy to egg or chicken
proteins; no latex allergy; no history of cancer, inflammatory disease or cardiovascular disease; no
chronic obstructive pulmonary disorder, diabetes mellitus, asthma, congestive heart failure, Guillain
Barre syndrome or psychiatric disorder; no females who were pregnant or breastfeeding; no current in-
fection; and no medication or medical condition which may influence immune function"
Long 2012 
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EXCLUSION CRITERIA Not reported
RECRUITMENT West Midlands area via local newspapers, flyers, email and Internet advertisements, lo-
cal community group visits, and by word of mouth
N SCREENED 161 participants N RANDOMISED 122 participants N COMPLETED 120 participants
GENDER Not reported
AGE 18 to 30 years cohort; 50 to 64 years cohort
Interventions SETTING OF INTERVENTION
Participants attended the laboratory on 2 separate occasions, 1 month apart
DESCRIPTION OF INTERVENTION
"Participants in the intervention group wore a heart rate monitor throughout the walk; average heart
rate was used as a marker of physical activity intensity. After completing a warm-up lap and a series of
lower body isometric muscle stretches, participants were instructed to walk at a brisk pace for 45 min
around a specified route while maintaining their heart rate at or above 55% of their heart rate maxi-
mum, calculated as 220 minus age. The walking route included sections of uphill and downhill walking
to elicit both concentric and eccentric contractions of the muscles. After the intervention, participants
carried out a cool down involving isometric muscle stretches."
DELIVERY Not reported
CONTROL GROUP Sat quietly in the laboratory for 45 minutes prior to receiving the vaccinations
CO-INTERVENTIONS None
Outcomes PRESPECIFIED OUTCOME MEASURES Health behaviours, IgG and IgM pneumococcal, influenza anti-
body titres, cardiac responses to intervention
GROUP ALLOCATIONS Exercise group: allocated n = 60, analysed at 4 weeks n = 60; Control group: allo-
cated n = 60, analysed at 4 weeks n = 60
FOLLOW-UP PERIOD 4 weeks
Notes TRIAL REGISTRATION Not reported
ETHICS All participants gave written informed consent and the study was approved by the South Birm-
ingham Local Research Ethics Committee
FUNDING Not reported
CONFLICTS OF INTEREST No conflicts of interest declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk "randomised into two groups, with an equal number of males and females in
each group"
Allocation concealment
(selection bias)
Unclear risk No information provided
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk Participants were not blind to exercise or control
Long 2012  (Continued)
Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
24
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk No information provided
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 1% dropout rate
Selective reporting (re-
porting bias)
Low risk The outcomes proposed in the Methods are reported in the Results. However,
study protocol was not registered
Other bias Low risk None found
Long 2012  (Continued)
 
 
Methods AIMS AND OBJECTIVES
"To evaluate the effect of acute moderate aerobic exercise immediately before administration of the in-
fluenza vaccine on antibody titres and seroprotective responses in older adults. To investigate whether
acute exercise immediately before influenza vaccination produces different effects on antibody re-
sponse in older men versus older women."
STUDY DESIGN Randomised, counterbalanced, cross-over design
DATES OF STUDY IMPLEMENTATION Not known
STUDY DURATION 6 weeks
SETTING, NUMBER OF CENTRES University of Illinois at Urbana-Champaign
Participants INCLUSION CRITERIA "All subjects were free from cardiovascular or respiratory disease, and none
smoked. A stress test was performed on visit 1 to exclude any participant with evidence of stress-in-
duced ischaemia"
EXCLUSION CRITERIA "Participants were excluded if they had metabolic disease (diabetes mellitus),
inflammatory diseases (rheumatoid arthritis and systemic lupus erythematosus), or bleeding disor-
der; were taking medications known to affect inflammation (aspirin); and had a history of smoking (any
form). Participants who had suffered from common cold or influenza and bacterial or viral infection or
upper respiratory tract infection 2 months preceding testing were also excluded. Participants who had
already received influenza vaccination for the season or who were taking thyroid medication or allergy
medication on a regular basis were excluded as well. Participants were also excluded if they were tak-
ing over-the-counter pain/anti-inflammatory medication during the course of the study."
RECRUITMENT All participants were recruited from the local community and provided written in-
formed consent before participation
N SCREENED 59 participants N RANDOMISED 59 participants N COMPLETED 55 participants
GENDER (completed) 23 men, 32 women
AGE 66.5 ± 0.8 years
Interventions SETTING Temperature-controlled room
DESCRIPTION OF INTERVENTION Exercise group performed a 40-min moderate-intensity aerobic ex-
ercise bout at an intensity of 55% to 65% of their maximum HR immediately preceding the vaccination
and sham injection
DELIVERY Not reported
Ranadive 2014 
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COMPARATOR GROUP Non-exercise group did not perform physical activity preceding vaccination; re-
ceived sham injection
CO-INTERVENTIONS None
Outcomes PRESPECIFIED OUTCOME MEASURES Influenza antibody titres, anthropometrics, brachial blood pres-
sure, hemagglutination inhibition titre, inflammatory markers
GROUP ALLOCATIONS Exercise group: allocated n = 30, analysed at 4 weeks n = 29; Control group: allo-
cated n = 29, analysed at 4 weeks n = 27
FOLLOW-UP PERIOD 4 weeks
Notes TRIAL REGISTRATION Not registered
ETHICS Approved by the Institutional Review Board of the University of Illinois at Urbana-Champaign
FUNDING Authors thanked the American Heart Association for the 2-yr pre-doctoral fellowship (no.
10PRE3500083)
CONFLICTS OF INTEREST The authors declared no conflicts of interest
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk "...randomised to an acute exercise or to a non-exercise group". Method of ran-
domisation not reported
Allocation concealment
(selection bias)
Unclear risk No information provided
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Low risk "The participant and the researchers were blinded to when they received the
vaccine or sham injection"
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk No information provided
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 7% dropout rate
Selective reporting (re-
porting bias)
Unclear risk The outcomes proposed in the Methods are reported in the Results. However,
no study protocol was registered
Other bias High risk "...the cohort included older individuals who are sedentary as well as physical-
ly active and did not control it"
Ranadive 2014  (Continued)
Abbreviations: HIA - hemagglutination inhibition assay; HR - heart rate; IgG - immunoglobulin G; IgM - immunoglobulin M; IL - interleukin;
RM - repetition maximum; SD - standard deviation
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Study Reason for exclusion
Hara 2002 Not RCT. Study analysed physical activity level as an outcome
Kohut 2002 Not RCT. Study included a control group but randomisation was not conducted
Kohut 2004 RCT. Control group had participants exercising (low intensity) and participants not exercising to-
gether in the control group
Whitham 2003 Not RCT. Heavy versus light exercise training groups. No non-exercise group
Woods 2009 RCT. Control group participants engaged in low intensity exercise
Yang 2007 Not RCT. Study included a control group but randomisation was not conducted
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Comparison 1.   Exercise versus no exercise prior to influenza vaccination
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Blood parameters- Antibody titre - Follow-up over
time
5   Std. Mean Difference (IV, Random,
95% CI)
Subtotals
only
1.1 Antibody titres viral strain A - up to 6 weeks fol-
low-up after vaccination
5 490 Std. Mean Difference (IV, Random,
95% CI)
-0.05 [-0.28,
0.18]
1.2 Antibody titres viral strain B - up to 6 weeks fol-
low-up after vaccination
5 490 Std. Mean Difference (IV, Random,
95% CI)
-0.11 [-0.29,
0.08]
1.3 Antibody titres viral strain A - over 6 weeks fol-
low-up after vaccination
2 155 Std. Mean Difference (IV, Random,
95% CI)
0.09 [-0.23,
0.41]
1.4 Antibody titres viral strain B - over 6 weeks fol-
low-up after vaccination
2 155 Std. Mean Difference (IV, Random,
95% CI)
-0.23 [-0.70,
0.25]
2 Blood parameters - Antibody titre - Timing of vacci-
nation
5   Std. Mean Difference (IV, Random,
95% CI)
Subtotals
only
2.1 Antibody titres viral strain A - Exercise immedi-
ately prior to vaccination - up to 6 weeks follow-up
4 392 Std. Mean Difference (IV, Random,
95% CI)
-0.14 [-0.35,
0.07]
2.2 Antibody titres viral strain B - Exercise immedi-
ately prior to vaccination - up to 6 weeks follow-up
4 392 Std. Mean Difference (IV, Random,
95% CI)
-0.14 [-0.36,
0.07]
2.3 Antibody titres viral strain A - Exercise immedi-
ately prior to vaccination - over 6 weeks follow-up
1 57 Std. Mean Difference (IV, Random,
95% CI)
0.14 [-0.41,
0.68]
2.4 Antibody titres viral strain B - Exercise immedi-
ately prior to vaccination - over 6 weeks follow-up
1 57 Std. Mean Difference (IV, Random,
95% CI)
-0.51 [-1.07,
0.04]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
2.5 Antibody titres viral strain A - Vaccination after 6
weeks of exercise
1 98 Std. Mean Difference (IV, Random,
95% CI)
0.06 [-0.33,
0.46]
2.6 Antibody titres viral strain B - Vaccination after 6
weeks of exercise
1 98 Std. Mean Difference (IV, Random,
95% CI)
-0.02 [-0.42,
0.37]
3 Blood parameters - Antibody titre - Type of exer-
cise
5   Std. Mean Difference (IV, Random,
95% CI)
Subtotals
only
3.1 Antibody titres viral strain A - Resistance exercise
prior to vaccination - up to 6 weeks follow-up
2 217 Std. Mean Difference (IV, Random,
95% CI)
0.01 [-0.29,
0.31]
3.2 Antibody titres viral strain B - Resistance exercise
prior to vaccination - up to 6 weeks follow-up
2 217 Std. Mean Difference (IV, Random,
95% CI)
-0.08 [-0.38,
0.22]
3.3 Antibody titres viral strain A - Endurance exercise
prior to vaccination - up to 6 weeks follow-up
2 175 Std. Mean Difference (IV, Random,
95% CI)
-0.28 [-0.58,
0.02]
3.4 Antibody titres viral strain B - Endurance exercise
prior to vaccination - up to 6 weeks follow-up
2 175 Std. Mean Difference (IV, Random,
95% CI)
-0.21 [-0.50,
0.09]
3.5 Antibody titres viral strain A - Resistance exercise
immediately prior to vaccination - over 6 weeks fol-
low-up
1 57 Std. Mean Difference (IV, Random,
95% CI)
0.14 [-0.41,
0.68]
3.6 Antibody titres viral strain B - Resistance exercise
immediately prior to vaccination - over 6 weeks fol-
low-up
1 57 Std. Mean Difference (IV, Random,
95% CI)
-0.51 [-1.07,
0.04]
3.7 Antibody titres viral strain A - Endurance exercise
for 8 weeks then vaccination
1 98 Std. Mean Difference (IV, Random,
95% CI)
0.06 [-0.33,
0.46]
3.8 Antibody titres viral strain B - Endurance exercise
for 8 weeks then vaccination
1 98 Std. Mean Difference (IV, Random,
95% CI)
-0.02 [-0.42,
0.37]
 
 
Analysis 1.1.   Comparison 1 Exercise versus no exercise prior to influenza
vaccination, Outcome 1 Blood parameters- Antibody titre - Follow-up over time.
Study or subgroup Exercise Non-exercise Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
1.1.1 Antibody titres viral strain A - up to 6 weeks follow-up after vaccination  
Edwards 2007 38 1.9 (1.4) 19 2.2 (0.7) 13.75% -0.21[-0.76,0.34]
Edwards 2010 120 242.5
(237.8)
40 218.5
(220.4)
24.96% 0.1[-0.26,0.46]
Hayney 2014 47 149.8 (37.2) 51 139.9 (33.2) 21.88% 0.28[-0.12,0.68]
Long 2012 60 3.7 (0.5) 60 3.9 (0.5) 24.81% -0.3[-0.65,0.06]
Ranadive 2014 28 3 (1.6) 27 3.4 (1.6) 14.6% -0.25[-0.78,0.28]
Subtotal *** 293   197   100% -0.05[-0.28,0.18]
Heterogeneity: Tau2=0.02; Chi2=5.97, df=4(P=0.2); I2=32.99%  
Test for overall effect: Z=0.44(P=0.66)  
Exercise 10.5-1 -0.5 0 Non-exercise
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Study or subgroup Exercise Non-exercise Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
   
1.1.2 Antibody titres viral strain B - up to 6 weeks follow-up after vaccination  
Edwards 2007 38 1.8 (12.9) 19 2.1 (0.7) 11.45% -0.03[-0.58,0.52]
Edwards 2010 120 1152 (686) 40 1220 (544) 27.1% -0.1[-0.46,0.25]
Hayney 2014 47 55.8 (28.1) 51 53.5 (188.5) 22.11% 0.02[-0.38,0.41]
Long 2012 60 2.8 (0.9) 60 3 (0.9) 26.97% -0.21[-0.57,0.15]
Ranadive 2014 28 2.5 (2.1) 27 2.9 (2.1) 12.37% -0.19[-0.72,0.34]
Subtotal *** 293   197   100% -0.11[-0.29,0.08]
Heterogeneity: Tau2=0; Chi2=0.88, df=4(P=0.93); I2=0%  
Test for overall effect: Z=1.14(P=0.25)  
   
1.1.3 Antibody titres viral strain A - over 6 weeks follow-up after vaccination  
Edwards 2007 37 1.3 (0.7) 20 1.2 (0.4) 34.63% 0.14[-0.41,0.68]
Hayney 2014 47 107.4 (33.2) 51 105.2 (33.4) 65.37% 0.06[-0.33,0.46]
Subtotal *** 84   71   100% 0.09[-0.23,0.41]
Heterogeneity: Tau2=0; Chi2=0.04, df=1(P=0.83); I2=0%  
Test for overall effect: Z=0.54(P=0.59)  
   
1.1.4 Antibody titres viral strain B - over 6 weeks follow-up after vaccination  
Edwards 2007 37 0.9 (0.8) 20 1.3 (0.4) 41.99% -0.51[-1.07,0.04]
Hayney 2014 47 46.6 (26.9) 51 47.2 (28.5) 58.01% -0.02[-0.42,0.37]
Subtotal *** 84   71   100% -0.23[-0.7,0.25]
Heterogeneity: Tau2=0.06; Chi2=2, df=1(P=0.16); I2=50.09%  
Test for overall effect: Z=0.94(P=0.35)  
Test for subgroup differences: Chi2=1.55, df=1 (P=0.67), I2=0%  
Exercise 10.5-1 -0.5 0 Non-exercise
 
 
Analysis 1.2.   Comparison 1 Exercise versus no exercise prior to influenza
vaccination, Outcome 2 Blood parameters - Antibody titre - Timing of vaccination.
Study or subgroup Exercise Non-exercise Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
1.2.1 Antibody titres viral strain A - Exercise immediately prior to vaccination -
up to 6 weeks follow-up
 
Edwards 2007 38 1.9 (1.4) 19 2.2 (0.7) 14.67% -0.21[-0.76,0.34]
Edwards 2010 120 242.5
(237.8)
40 218.5
(220.4)
34.9% 0.1[-0.26,0.46]
Long 2012 60 3.7 (0.5) 60 3.9 (0.5) 34.55% -0.3[-0.65,0.06]
Ranadive 2014 28 3 (1.6) 27 3.4 (1.6) 15.87% -0.25[-0.78,0.28]
Subtotal *** 246   146   100% -0.14[-0.35,0.07]
Heterogeneity: Tau2=0; Chi2=2.7, df=3(P=0.44); I2=0%  
Test for overall effect: Z=1.27(P=0.2)  
   
1.2.2 Antibody titres viral strain B - Exercise immediately prior to vaccination -
up to 6 weeks follow-up
 
Edwards 2007 38 1.8 (12.9) 19 2.1 (0.7) 14.7% -0.03[-0.58,0.52]
Edwards 2010 120 1152 (686) 40 1220 (544) 34.79% -0.1[-0.46,0.25]
Long 2012 60 2.8 (0.9) 60 3 (0.9) 34.62% -0.21[-0.57,0.15]
Ranadive 2014 28 2.5 (2.1) 27 2.9 (2.1) 15.88% -0.19[-0.72,0.34]
Subtotal *** 246   146   100% -0.14[-0.36,0.07]
Exercise 21-2 -1 0 Non-exercise
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Study or subgroup Exercise Non-exercise Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Heterogeneity: Tau2=0; Chi2=0.39, df=3(P=0.94); I2=0%  
Test for overall effect: Z=1.34(P=0.18)  
   
1.2.3 Antibody titres viral strain A - Exercise immediately prior to vaccination -
over 6 weeks follow-up
 
Edwards 2007 37 1.3 (0.7) 20 1.2 (0.4) 100% 0.14[-0.41,0.68]
Subtotal *** 37   20   100% 0.14[-0.41,0.68]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.49(P=0.62)  
   
1.2.4 Antibody titres viral strain B - Exercise immediately prior to vaccination -
over 6 weeks follow-up
 
Edwards 2007 37 0.9 (0.8) 20 1.3 (0.4) 100% -0.51[-1.07,0.04]
Subtotal *** 37   20   100% -0.51[-1.07,0.04]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.82(P=0.07)  
   
1.2.5 Antibody titres viral strain A - Vaccination after 6 weeks of exercise  
Hayney 2014 47 107.4 (33.2) 51 105.2 (33.4) 100% 0.06[-0.33,0.46]
Subtotal *** 47   51   100% 0.06[-0.33,0.46]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.32(P=0.75)  
   
1.2.6 Antibody titres viral strain B - Vaccination after 6 weeks of exercise  
Hayney 2014 47 46.6 (26.9) 51 47.2 (28.5) 100% -0.02[-0.42,0.37]
Subtotal *** 47   51   100% -0.02[-0.42,0.37]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.11(P=0.92)  
Exercise 21-2 -1 0 Non-exercise
 
 
Analysis 1.3.   Comparison 1 Exercise versus no exercise prior to influenza
vaccination, Outcome 3 Blood parameters - Antibody titre - Type of exercise.
Study or subgroup Exercise Non-exercise Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
1.3.1 Antibody titres viral strain A - Resistance exercise prior to vaccination - up
to 6 weeks follow-up
 
Edwards 2007 38 1.9 (1.4) 19 2.2 (0.7) 29.6% -0.21[-0.76,0.34]
Edwards 2010 120 242.5
(237.8)
40 218.5
(220.4)
70.4% 0.1[-0.26,0.46]
Subtotal *** 158   59   100% 0.01[-0.29,0.31]
Heterogeneity: Tau2=0; Chi2=0.87, df=1(P=0.35); I2=0%  
Test for overall effect: Z=0.06(P=0.95)  
   
1.3.2 Antibody titres viral strain B - Resistance exercise prior to vaccination -
up to 6 weeks follow-up
 
Edwards 2007 38 1.8 (12.9) 19 2.1 (0.7) 29.71% -0.03[-0.58,0.52]
Edwards 2010 120 1152 (686) 40 1220 (544) 70.29% -0.1[-0.46,0.25]
Subtotal *** 158   59   100% -0.08[-0.38,0.22]
Heterogeneity: Tau2=0; Chi2=0.05, df=1(P=0.82); I2=0%  
Test for overall effect: Z=0.53(P=0.6)  
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Study or subgroup Exercise Non-exercise Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
   
1.3.3 Antibody titres viral strain A - Endurance exercise prior to vaccination - up
to 6 weeks follow-up
 
Long 2012 60 3.7 (0.5) 60 3.9 (0.5) 68.52% -0.3[-0.65,0.06]
Ranadive 2014 28 3 (1.6) 27 3.4 (1.6) 31.48% -0.25[-0.78,0.28]
Subtotal *** 88   87   100% -0.28[-0.58,0.02]
Heterogeneity: Tau2=0; Chi2=0.02, df=1(P=0.89); I2=0%  
Test for overall effect: Z=1.85(P=0.06)  
   
1.3.4 Antibody titres viral strain B - Endurance exercise prior to vaccination -
up to 6 weeks follow-up
 
Long 2012 60 2.8 (0.9) 60 3 (0.9) 68.55% -0.21[-0.57,0.15]
Ranadive 2014 28 2.5 (2.1) 27 2.9 (2.1) 31.45% -0.19[-0.72,0.34]
Subtotal *** 88   87   100% -0.21[-0.5,0.09]
Heterogeneity: Tau2=0; Chi2=0.01, df=1(P=0.94); I2=0%  
Test for overall effect: Z=1.36(P=0.17)  
   
1.3.5 Antibody titres viral strain A - Resistance exercise immediately prior to
vaccination - over 6 weeks follow-up
 
Edwards 2007 37 1.3 (0.7) 20 1.2 (0.4) 100% 0.14[-0.41,0.68]
Subtotal *** 37   20   100% 0.14[-0.41,0.68]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.49(P=0.62)  
   
1.3.6 Antibody titres viral strain B - Resistance exercise immediately prior to
vaccination - over 6 weeks follow-up
 
Edwards 2007 37 0.9 (0.8) 20 1.3 (0.4) 100% -0.51[-1.07,0.04]
Subtotal *** 37   20   100% -0.51[-1.07,0.04]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.82(P=0.07)  
   
1.3.7 Antibody titres viral strain A - Endurance exercise for 8 weeks then vacci-
nation
 
Hayney 2014 47 107.4 (33.2) 51 105.2 (33.4) 100% 0.06[-0.33,0.46]
Subtotal *** 47   51   100% 0.06[-0.33,0.46]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.32(P=0.75)  
   
1.3.8 Antibody titres viral strain B - Endurance exercise for 8 weeks then vacci-
nation
 
Hayney 2014 47 46.6 (26.9) 51 47.2 (28.5) 100% -0.02[-0.42,0.37]
Subtotal *** 47   51   100% -0.02[-0.42,0.37]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.11(P=0.92)  
Exercise 21-2 -1 0 Non-exercise
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Study name/location Partici-
pants ran-
% women Age Participant characteristics
Table 1.   Included study participant characteristics at baseline 
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domised/with-
drew
Edwards 2007UK 60/3 51% 20.35 ± 2.09 years Physically active students
Edwards 2010UK 160/2 51% 20.5 ± 1.6 years Mean BMI = 21.6 ± 2.6 kg/m2
Edwards 2013UK (Ab-
stract only)
46/0 50% 73 ± 7 years Mean BMI = 27.20 ± 5 kg/m2
Hayney 2014USA 154/5 81.8% 50 years and over Healthy, sedentary
Long 2012UK 122/2 NR 18 to 30 years cohort;
50 to 64 years cohort
Mean BMI = 24.50 ± 4.23 kg/m2
Mean BMI = 25.97 ± 4.12 kg/m2
Ranadive 2014USA 59/4 54% 66.5 ± 0.85 Mean BMI = 25.55 ± 0.9 kg/m2
Table 1.   Included study participant characteristics at baseline  (Continued)
Abbreviations: BMI - body mass index; NR - not reported
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ID
Study
loca-
tion/s
Exercise type Frequen-
cy
Intensi-
ty
Duration Supervi-
sion
Control
group
Timing of Influenza
vaccination
Participant fol-
low-up
Outcomes in meta-
analysis
Edwards
2007UK
Biceps curl and
lateral raise
1 session 85% of 1
RM
25 min (6 sets
of 7 repeti-
tions and 2
sets of 4 repe-
titions)
Super-
vised
Quiet
resting
Exercise immediately
before vaccination
6, 8, 20 weeks
post-vaccination
Adverse effects; blood
parameters
Edwards
2010UK
Non-dominant
arm biceps curl
and lateral raise
1 session 60% of 1
RM; 85%
of 1 RM;
110% of
1 RM
25 min (10
sets of 5 repe-
titions)
Super-
vised
Quiet
resting
Exercise immediately
before vaccination
4 weeks post-vac-
cination
Adverse effects; blood
parameters
Edwards
2013UK
Resistance upper
and lower body
1 session 60% of 1
RM
50 minutes NR Quiet
reading
Exercise immediately
before vaccination
4 weeks post-vac-
cination
None
Hayney
2014
USA
Bicycle, treadmill
and brisk walk
1 week
session
(2½ hours)
+
45 min-
utes
daily
home
practice
12 to
16 Borg
scale
8 weeks 1 week
session
super-
vised
by exer-
cise
physiol-
ogist
Medita-
tion
and no
exercise
6 months after exer-
cise
12 weeks post-
vaccination
Incidence of influen-
za; number of working
days lost; blood para-
meters
Long
2012UK
Walk 1 session 55%
MHR
45 minutes No su-
pervi-
sion
Quiet sit-
ting
Exercise immediately
before vaccination
4 weeks post-vac-
cination
Adverse effects; blood
parameters
Ranadive
2014USA
Aerobic exercise 1 session 55%
to 65%
MHR
40 minutes NR NR Exercise immediately
before vaccination
4 weeks post-vac-
cination
Blood parameters
Table 2.   Characteristics of exercise intervention and timing of influenza vaccination 
Abbreviations: HRR - heart rate reserve; ID - identification; MHR - maximum heart rate; NR - not reported; RM - repetition maximum
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A P P E N D I C E S
Appendix 1. MEDLINE (OVID)
1 exp INFLUENZA/
2 influenza.mp.
3 or/1-2
4 exp VACCINES/
5 exp VACCINATION/
6 (immuniz$ or immunis$).mp.
7 vaccin$.mp.
8 or/4-7
9 3 and 8
10 exp Influenza Vaccine/
11 (influenz$ adj (vaccin$ or immun$)).mp.
12 or/10-11
13 9 or 12
14 exp Exercise/
15 exp Exercise Movement Techniques/
16 exp Exercise Therapy/
17 Physical Fitness/
18 physical endurance/ or exercise tolerance/
19 Physical Exertion/
20 exp Sports/
21 Dancing/
22 (exercis* or sport* or fitness* or gym* or aerobic*).tw.
23 ((weight* or strength* or enduranc* or circuit*) adj5 (program* or train* or session*)).tw.
24 (physical* adj5 (fit* or activ* or movement* or train* or condition* or program*)).tw.
25 (activ* adj2 life*).tw.
26 (run* or walk* or jog* or sprint* or treadmill* or row* or swim* or bicycl* or cycl* or danc* or yoga or tai chi or tai ji or qigong or qi gong).tw.
27 or/14-26
28 13 and 27
Appendix 2. Embase search strategy
#23 #11 AND #22
#22 #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21
#21 run*:ab,ti OR walk*:ab,ti OR jog*:ab,ti OR sprint*:ab,ti OR treadmill*:ab,ti OR row*:ab,ti OR swim*:ab,ti OR bicycl*:ab,ti OR cycl*:ab,ti
OR danc*:ab,ti OR yoga:ab,ti OR 'tai chi':ab,ti OR 'tai ji':ab,ti OR qigong:ab,ti OR 'qi gong':ab,ti AND [embase]/lim
#20 (activ* NEAR/2 life*):ab,ti AND [embase]/lim
#19 (physical* NEAR/5 (fit* OR activ* OR movement* OR train* OR condition* OR program*)):ab,ti AND [embase]/lim
#18 ((weight* OR strength* OR enduranc* OR circuit*) NEAR/5 (program* OR train* OR session*)):ab,ti AND [embase]/lim
#17exercis*:ab,ti OR sport*:ab,ti OR fitness*:ab,ti OR gym*:ab,ti OR aerobic*:ab,ti AND [embase]/lim
#16 'sport'/exp AND [embase]/lim
#15 'training'/de OR 'endurance'/de OR 'exercise tolerance'/de OR 'physical capacity'/de AND [embase]/lim
#14 'physical activity'/exp OR 'physical activity, capacity and performance'/de AND [embase]/lim
#13 'kinesiotherapy'/exp AND [embase]/lim
#12 'exercise'/exp AND [embase]/lim
#11 #1 OR #10
#10 #5 AND #9
#9 #6 OR #7 OR #8
#8 immuniz*:ab,ti OR immunis*:ab,ti
#7 ’immunization’/exp
#6 ’vaccine’/exp OR ’vaccination’/de
#5 #2 OR #3 OR #4
#4 ’influenza virus a’/exp OR ’influenza virus b’/de
#3 influenza*:ab,ti OR flu:ab,ti
#2 ’influenza’/exp
#1 ’influenza vaccine’/de
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Appendix 3. CINAHL search strategy
S38 S28 AND S37
S37 S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36
S36 (MH "Quantitative Studies")
S35 TI placebo* OR AB placebo*
S34 (MH "Placebos")
S33 TI random* OR AB random*
S32 TI ((singl* or doubl* or tripl* or trebl*) W1 (blind* or mask*)) OR AB ((singl* or doubl* or tripl* or trebl*) W1 (blind* or mask*))
S31 TI clinic* W1 trial* OR AB clinic* W1 trial*
S30 PT clinical trial
S29 (MH "Clinical Trials+")
S28 S14 AND S27
S27 S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26
S26 TI (run* or walk* or jog* or sprint* or treadmill* or row* or swim* or bicycl* or cycl* or danc* or yoga or tai chi or tai ji or qigong or qi
gong) OR AB (run* or walk* or jog* or sprint* or treadmill* or row* or
swim* or bicycl* or cycl* or danc* or yoga or tai chi or tai ji or qigong or qi gong)
S25 TI activ* N5 life* OR AB activ* N5 life*
S24 TI (physical* N5 (fit* or activ* or movement* or train* or condition* or program*)) OR AB (physical* N5 (fit* or activ* or movement*
or train* or condition* or program*))
S23 TI ( (weight* or strength* or enduranc* or circuit*) N5 (program* or train* or session*)) OR AB ((weight* or strength* or enduranc* or
circuit*) N5 (program* or train* or session*))
S22 TI (exercis* or sport* or fitness* or gym* or aerobic*) OR AB (exercis* or sport* or fitness* or gym* or aerobic*)
S21 (MH "Dancing+")
S20 (MH "Sports+")
S19 (MH "Exertion") OR (MH "Exercise Intensity")
S18 (MH "Physical Endurance+")
S17 (MH "Physical Fitness+")
S16 (MH "Therapeutic Exercise+")
S15 (MH "Exercise+")
S14 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13
S13 TI (ari or urti or lrti) OR AB (ari or urti or lrti)
S12 TI (bronchit* or pneumon* or bronchopneumon* or pleuropneumon*) OR AB (bronchit* or pneumon* or bronchopneumon* or pleu-
ropneumon*)
S11 TI (sinusit* or rhinosinusit* or nasosinusit*) OR AB (sinusit* or rhinosinusit* or nasosinusit*)
S10 TI cough* OR AB cough*
S9 (MH "Cough")
S8 TI (nasopharyngit* or rhinopharyngit*) OR AB (nasopharyngit* or rhinopharyngit*)
S7 TI (throat* N3 (infect* or inflam*)) OR AB (throat* N3 (infect* or inflam*))
S6 TI (pharyngit* or laryngit* or tonsillit* or sore throat*) OR AB (pharyngit* or laryngit* or tonsillit* or sore thoat*)
S5 TI (influenza* or flu or ili) OR AB (influenza* or flu or ili)
S4 TI ((acute or viral or virus* or bacter*) N2 rhinit*) OR AB ((acute or viral or virus* or bacter*) N2 rhinit*)
S3 TI (common cold* or colds or coryza) OR AB (common cold* or colds or coryza)
S2 TI (respiratory N2 (infect* or illness or symptom* or acute or virus*)) OR AB (respiratory N2 (infect* or illness or symptom* or acute or
virus*))
S1 (MH "Respiratory Tract Infections") OR (MH "Bronchitis") OR (MH "Bronchitis, Acute") OR (MH "Common Cold") OR (MH "Influenza")
OR (MH "Influenza, Human") OR (MH "Influenza, Seasonal") OR (MH "Laryngitis") OR (MH "Pharyngitis") OR (MH "Pneumonia+") OR (MH
"Sinusitis+") OR (MH "Tonsillitis")
Appendix 4. LILACS search strategy
MH:"Respiratory Tract Infections" OR "Upper Respiratory Tract Infections" OR MH:C01.539.739$ OR MH:C08.730$ OR MH:Bronchitis OR
MH:C08.127.446$ OR MH:C08.381.495.146 OR MH:C08.730.099 OR MH:"Common Cold" OR MH:C02.782.687.207$ OR MH:C08.730.162$
OR "Cold, Common" OR "Coryza, Acute" OR MH:"Influenza, Human" OR MH:C02.782.620.365$ OR MH:C08.730.310$ OR Grippe
OR "Human Flu" OR "Human Influenza" OR "Influenza in Humans" OR MH:Laryngitis OR MH:C08.360.535 OR MH:C08.730.368 OR
MH:C09.400.535 OR MH:Pharyngitis OR MH:C07.550.781$ OR MH:C08.730.561$ OR MH:C09.775.649$ OR "Sore Throat" OR MH:C08.381.677$
OR MH:08.730.610$ OR "Experimental Lung Inflammation" OR "Lobar Pneumonia" OR "Lung Inflammation" OR "Pulmonary In-
flammation" OR MH:Sinusitis OR MH:C08.460.692.752$ OR MH:C08.730.749$ OR MH:C09.603.692.752$ OR MH:Nasopharyngitis OR
MH:C07.550.350.700$ OR MH:C07.550.781.500$ OR MH:C08.730.561.500$ OR MH:C09.775.350.700$ OR MH:C09.775.649.500$ OR MH:Cough
OR MH:Tos OR MH:Tosse OR MH:C08.618.248$ MH:C23.888.852.293$ OR MH:Bronchitis OR MH:Bronquitis OR MH:Bronquite OR
MH:C08.127.446$ OR MH:C08.381.495.146$ OR MH:C08.730.099$ OR MH:Bronconeumonía OR MH:C08.127.509$ OR MH:C08.381.677.127$
OR MH:C08.730.610.127$ OR MH:Pleuropneumonia OR MH:C08.381.677.473$ OR MH:C08.528.735.473$ OR MH:C08.730.582.473$ OR
MH:C08.730.610.473$ AND MH:Exercise OR "Aerobic Exercise" OR "Exercise, Aerobic" OR "Exercise, Isometric" OR "Exercise,
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Physical" OR "Isometric Exercise" OR MH:G11.427.590.530.698.277$ OR MH:I03.350$ OR MH:"Exercise Movement Techniques" OR
MH:"Exercise Therapy" OR OR MH:E02.779.483$ OR MH:E02.831.387$ OR MH:"Physical Fitness" OR "Physical Conditioning, Hu-
man" OR MH:I03.621$ OR MH:N01.400.545$ OR MH:"Physical Endurance" OR MH:G11.427.680$ OR MH:I03.450.642.845.054.600$
OR MH:"Exercise Tolerance" OR MH:G11.427.680.270$ OR MH: "Physical Exertion" OR "Physical Effort" OR MH:G11.427.590.780$
OR MH:Sports OR Athletics OR MH:I03.450.642.845$ OR MH:Dancing OR MH:I03.450.642.287$ OR MH:Gymnastics OR Calisthen-
ics OR MH:I02.233.543.454$ OR MH:I03.450.642.845.417$ OR MH:"Weight Lifting" OR MH:I03.450.642.845.950$ OR MH:"Muscle
Strength" OR MH:E01.370.600.425$ OR MH:G11.427.560$ OR MH: "Physical Education and Training" OR MH:I02.233.543$ OR
MH:Running OR MH:G11.427.590.530.568.610$ OR MH:G11.427.590.530.698.277.750$ OR MH:I03.450.642.845.610$ OR MH:Jogging OR
MH:G11.427.590.530.568.610.320$ OR MH:G11.427.590.530.698.277.750.320$ OR MH:I03.450.642.845.610.320$ OR MH: "Exercise Test" OR
Bicycle OR "Ergometry Test" OR "Arm Ergometry Test" OR "Step Test" OR "Stress Test" OR "Treadmill Test" OR MH:E01.370.370.380.250$
OR MH:E01.370.386.700.250$ OR MH:E05.333.250$ OR "Prueba Ergométrica de Bicicleta" OR "Test Ergométrico de Bicicleta" OR MH:Swim-
ming OR Natación OR Natação OR MH:G11.427.590.530.568.800$ OR MH:G11.427.590.530.698.277.875$ OR MH:I03.450.642.845.869$ OR
MH:Bicycling OR MH:I03.450.642.845.140$ OR MH:Yoga OR MH:E02.190.525.937$ OR MH:E02.190.901.984$ OR MH:E02.779.474.937$ OR
MH:K01.844.799.867$ OR MH:"Tai Ji" OR MH:E02.190.525.890$ OR MH:E02.779.474.913$ OR MH:I03.450.642.845.560.500$ OR MH:"Breath-
ing Exercises" OR "Ch'i Kung" OR "Qi Gong" OR Qigong OR "Respiratory Muscle Training" OR MH:E02.190.525.186$ OR MH:E02.779.474.124$
OR "Ch'i Kung" OR "Qi Gong" OR Qigong
Appendix 5. PEDro search strategy
exercise AND vaccination
Appendix 6. SPORTDiscus search strategy
S40 S33 AND S39
S39 S34 OR S35 OR S36 OR S37 OR S38 OR S39
S38 TI ( crossover* or cross over* ) OR AB ( crossover* or cross over* )
S37 TI ( (singl* or doubl*) W1 (blind* or mask*) ) OR AB ( (singl* or doubl*) W1 (blind* or mask*) )
S36 TI trial
S35 TI clinic* W1 trial* OR AB clinic* W1 trial*
S34 TI placebo* OR AB placebo*
S33 TI random* OR AB random*
S32 S19 AND S31
S31 S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30
S30 TI ( run* or walk* or jog* or sprint* or treadmill* or row* or swim* or bicycl* or cycl* or danc* or yoga or tai chi or tai ji or qigong or qi
gong ) OR AB ( run* or walk* or jog* or sprint* or treadmill* or row* or
swim* or bicycl* or cycl* or danc* or yoga or tai chi or tai ji or qigong or qi gong )
S39 TI activ* N2 life* OR AB activ* N2 life*
S28 TI ( physical* N5 (fit* or activ* or movement* or train* or condition* or program*) ) OR AB ( physical* N5 (fit* or activ* or movement*
or train* or condition* or program*) )
S27 TI ( (weight* or strength* or enduranc* or circuit*) N5 (program* or train* or session*) ) OR AB ( (weight* or strength* or enduranc* or
circuit*) N5 (program* or train* or session*) )
S26 TI ( exercis* or sport* or fitness* or gym* or aerobic* ) OR AB ( exercis* or sport* or fitness* or gym* or aerobic* )
S25 DE "DANCE" OR DE "AERIAL dance" OR DE "AEROBIC dancing" OR DE "AFRICAN American dance" OR DE "BALLET" OR DE "BALLROOM
dancing" OR DE "BELLY dance" OR DE "BREAK dancing" OR DE "CHA-cha (Dance)" OR DE "COUNTRY dancing" OR DE "DANCE for people
with disabilities" OR DE "FLAMENCO" OR DE "FOLK dancing" OR DE "FREE skating" OR DE "HIP-hop dance" OR DE "ICE dancing" OR DE
"JAZZ dance" OR DE "LINE dancing" OR DE "LION dance" OR DE "MODERN dance" OR DE "MOVEMENT notation" OR DE "ORIGINAL set
pattern dance (Skating)" OR DE "POLE dancing" OR DE "ROUND dancing" OR DE "SALSA (Dance)" OR DE "SHISHIMAI (Dance)" OR DE
"SQUARE dancing" OR DE "STEP dancing" OR DE "TANGO (Dance)" OR DE "TAP dancing"
S24 DE "PHYSICAL training & conditioning" OR DE "ACROBATICS -- Training" OR DE "ALTITUDE training" OR DE "ANAEROBIC training" OR
DE "ARCHERY -- Training" OR DE "BADMINTON (Game) -- Training" OR DE "BASE training (Exercise)" OR DE "BASEBALL -- Training" OR DE
"BASKETBALL -- Training" OR DE "BICYCLE racing -- Training" OR DE "BODYBUILDING -- Training" OR DE "BOWLING -- Training" OR DE
"BOXING -- Training" OR DE "BULLFIGHT training & conditioning" OR DE "BUNGEE jumping training & conditioning" OR DE "CANOES &
canoeing -- Training" OR DE "CAVING training & conditioning" OR DE "COMPOUND exercises" OR DE "CONTRAST training (Physical train-
ing & conditioning)" OR DE "COXSWAINING -- Training" OR DE "CRICKET training & conditioning" OR DE "CROSS-training (Sports)" OR DE
"CYCLING -- Training" OR DE "DANCE training & conditioning" OR DE "DEEP diving training & conditioning" OR DE "DIVING -- Training" OR
DE "DOGSLEDDING training & conditioning" OR DE "ENDURANCE sports -- Training" OR DE "FENCING -- Training" OR DE "FIELD hockey
training & conditioning" OR DE "FOOTBALL -- Training" OR DE "FUNCTIONAL training" OR DE "GLIDING & soaring training & conditioning"
OR DE "GOLF -- Training" OR DE "GYMNASTICS -- Training" OR DE "HANDBALL training & conditioning" OR DE "HIKING training & condi-
tioning" OR DE "HOCKEY -- Training" OR DE "HUNTING training & conditioning" OR DE "INTERVAL training" OR DE "ISOLATION exercis-
es" OR DE "KAYAKING -- Training" OR DE "KNIFE fighting -- Training" OR DE "KORFBALL -- Training" OR DE "LACROSSE training & condi-
tioning" OR DE "LONG slow distance training" OR DE "MARTIAL arts -- Training" OR DE "MOTORSPORTS training & conditioning" OR DE
"MOUNTAINEERING -- Training" OR DE "NUNCHAKU -- Training" OR DE "ORIENTEERING -- Training" OR DE "OVERTRAINING" OR DE "PACE
training" OR DE "PARACHUTING training & conditioning" OR DE "PARAKITING training & conditioning" OR DE "PERIODIZATION training"
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OR DE "PERSONAL training" OR DE "POLO training & conditioning" OR DE "PRACTICE (Sports)" OR DE "PRESEASON (Sports)" OR DE "RAC-
QUETBALL -- Training" OR DE "RECOVERY training" OR DE "RELAY racing -- Training" OR DE "REPETITION training" OR DE "RESISTANCE
training (Physical training & conditioning)" OR DE "ROCK climbing -- Training" OR DE "RODEO training & conditioning" OR DE "ROLLER
skating training & conditioning" OR DE "ROWING -- Training" OR DE "RUGBY football -- Training" OR DE "RUNNING -- Training" OR DE
"SHOT putting -- Training" OR DE "SKATING -- Training" OR DE "SKIS & skiing -- Training" OR DE "SKYDIVING training & conditioning" OR
DE "SOCCER -- Training" OR DE "SOFTBALL -- Training" OR DE "SPEED endurance training" OR DE "SQUASH (Game) -- Training" OR DE
"STRENGTH training" OR DE "SURFING -- Training" OR DE "SWIMMING -- Training" OR DE "TABLE tennis training & conditioning" OR DE
"TEAM handball -- Training" OR DE "TENNIS -- Training" OR DE "TRACK & field -- Training" OR DE "TRIATHLON -- Training" OR DE "TUG of
war (Game) -- Training" OR DE "VAULTING (Horsemanship) -- Training" OR DE "VOLLEYBALL -- Training" OR DE "WATER polo -- Training"
OR DE "WEIGHT training" OR DE "WHEELCHAIR sports -- Training" OR DE "WINTER sports training & conditioning" OR DE "WRESTLING --
Training" OR DE "YOGA training & conditioning"
S23 DE "BALL games" OR DE "ANETSO" OR DE "BALL hockey" OR DE "BALLE au tamis (Game)" OR DE "BASEBALL" OR DE "BASKETBALL"
OR DE "BATTLE ball" OR DE "BICYCLE polo" OR DE "BILLIARDS" OR DE "BOWLING games" OR DE "BROOMBALL" OR DE "CAMOGIE (Game)"
OR DE "CRICKET (Sport)" OR DE "CROQUET" OR DE "DODGEBALL" OR DE "FIELD hockey" OR DE "FLICKERBALL" OR DE "FOOTBALL" OR DE
"GOAL ball" OR DE "GOLF" OR DE "GOLF croquet" OR DE "HANDBALL" OR DE "HURLING (Game)" OR DE "INDOOR hockey" OR DE "JAPANESE
polo" OR DE "JIAN zi (Game)" OR DE "KANG (Game)" OR DE "KICKBALL" OR DE "LACROSSE" OR DE "LAPTA (Game)" OR DE "LAWN tempest
(Game)" OR DE "MINTON (Game)" OR DE "PARLOR football" OR DE "PARLOR tennis" OR DE "PICKLE ball" OR DE "PICKLEBALL (Game)"
OR DE "PIZE-ball" OR DE "POLO" OR DE "POLOCROSSE" OR DE "PUSH ball" OR DE "QUIDDITCH (Game)" OR DE "RACQUETBALL" OR DE
"RAGA (Game)" OR DE "ROLL ball" OR DE "ROUNDERS" OR DE "RUGBALL" OR DE "SCHLAGBALL" OR DE "SHINTY (Game)" OR DE "SOCCER"
OR DE "SOFTBALL" OR DE "SPEED-a-way (Game)" OR DE "SPEEDBALL" OR DE "STICKBALL (Game)" OR DE "STOOLBALL" OR DE "TABLE
tennis" OR DE "TCHOUKBALL" OR DE "TENNIS" OR DE "TETHERBALL" OR DE "TRAPBALL" OR DE "VOLLEYBALL" OR DE "WALLYBALL" OR
DE "WATER polo" OR DE "WICKET" OR DE "WIFFLE ball"
S22 DE "EXERCISE tolerance"
S21 DE "PHYSICAL fitness" OR DE "ANAEROBIC exercises" OR DE "ASTROLOGY & physical fitness" OR DE "BODYBUILDING" OR DE "CARDIO-
VASCULAR fitness" OR DE "CIRCUIT training" OR DE "COMPOUND exercises" OR DE "ISOLATION exercises" OR DE "LIANGONG" OR DE
"MUSCLE strength" OR DE "PERIODIZATION training" OR DE "PHYSICAL fitness -- Genetic aspects" OR DE "PHYSICAL fitness for children"
OR DE "PHYSICAL fitness for girls" OR DE "PHYSICAL fitness for men" OR DE "PHYSICAL fitness for older people" OR DE "PHYSICAL fitness
for people with disabilities" OR DE "PHYSICAL fitness for women" OR DE "PHYSICAL fitness for youth" OR DE "SPORT for All"
S20 DE "EXERCISE" OR DE "ABDOMINAL exercises" OR DE "AEROBIC exercises" OR DE "ANAEROBIC exercises" OR DE "AQUATIC exercises"
OR DE "ARM exercises" OR DE "BACK exercises" OR DE "BREATHING exercises" OR DE "BREEMA" OR DE "BUTTOCKS exercises" OR DE
"CALISTHENICS" OR DE "CHAIR exercises" OR DE "CHEST exercises" OR DE "CIRCUIT training" OR DE "COMPOUND exercises" OR DE "DO-
in" OR DE "EXERCISE -- Immunological aspects" OR DE "EXERCISE adherence" OR DE "EXERCISE for children" OR DE "EXERCISE for girls" OR
DE "EXERCISE for men" OR DE "EXERCISE for middle-aged persons" OR DE "EXERCISE for older people" OR DE "EXERCISE for people with
disabilities" OR DE "EXERCISE for women" OR DE "EXERCISE for youth" OR DE "EXERCISE therapy" OR DE "EXERCISE video games" OR DE
"FACIAL exercises" OR DE "FALUN gong exercises" OR DE "FOOT exercises" OR DE "GYMNASTICS" OR DE "HAND exercises" OR DE "HATHA
yoga" OR DE "HIP exercises" OR DE "ISOKINETIC exercise" OR DE "ISOLATION exercises" OR DE "ISOMETRIC exercise" OR DE "ISOTONIC
exercise" OR DE "KNEE exercises" OR DE "LEG exercises" OR DE "LIANGONG" OR DE "METABOLIC equivalent" OR DE "MULAN quan" OR
DE "MUSCLE strength" OR DE "PILATES method" OR DE "PLYOMETRICS" OR DE "QI gong" OR DE "REDUCING exercises" OR DE "RUNNING"
OR DE "RUNNING -- Social aspects" OR DE "SCHOOLS -- Exercises & recreations" OR DE "SEXUAL exercises" OR DE "SHOULDER exercises"
OR DE "STRENGTH training" OR DE "STRESS management exercises" OR DE "STRETCHING exercises" OR DE "TAI chi" OR DE "TREADMILL
exercise" OR DE "WHEELCHAIR workouts" OR DE "YOGA"
S19 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18
S18 TI ( ari or urti or lrti ) OR AB ( ari or urti or lrti )
S17 TI ( bronchit* or pneumon* or bronchopneumon* or pleuropneumon* ) OR AB ( bronchit* or pneumon* or bronchopneumon* or
pleuropneumon* )
S16 TI ( sinusit* or rhinosinusit* or nasosinusit* ) OR AB ( sinusit* or rhinosinusit* or nasosinusit* )
S15 TI cough* OR AB cough*
S14 TI ( nasopharyngit* or rhinopharyngit* ) OR AB ( nasopharyngit* or rhinopharyngit* )
S13 TI ( throat* N3 (infect* or inflam*) ) OR AB ( throat* N3 (infect* or inflam*) )
S12 TI ( pharyngit* or laryngit* or tonsillit* or sore throat* ) OR AB ( pharyngit* or laryngit* or tonsillit* or sore thoat* )
S11 TI ( influenza* or flu or ili ) OR AB ( influenza* or flu or ili )
S10 TI ( (acute or viral or virus* or bacter*) N2 rhinit* ) OR AB ( (acute or viral or virus* or bacter*) N2 rhinit* )
S9 TI ( common cold* or colds or coryza ) OR AB ( common cold* or colds or coryza )
S8 TI ( respiratory N2 (infect* or illness or symptom* or acute or virus*) ) OR AB ( respiratory N2 (infect* or illness or symptom* or acute
or virus*) )
S7 DE "BRONCHITIS"
S6 DE "COUGH"
S5 DE "PNEUMONIA"
S4 DE "SINUSITIS"
S3 DE "INFLUENZA"
S2 DE "COLD (Disease)"
S1 DE "RESPIRATORY infections"
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We added subset analysis to assess vaccination timing because we felt it was important to distinguish if vaccination was administered im-
mediately after exercise or some time before vaccination. We deleted the comparison 'Exercise with influenza vaccination versus exercise
with placebo vaccination' from the review, since this outcome was not addressed in studies.
We deleted a secondary outcome proposed in our protocol: 'Exercise compliance rates of participants'. We made this exclusion because
it was not an outcome of the intervention.
I N D E X   T E R M S
Medical Subject Headings (MeSH)
*Exercise;  *Vaccination;  Incidence;  Influenza Vaccines  [*administration & dosage]  [adverse eCects];  Influenza, Human  [complications]
 [epidemiology]  [*prevention & control];  Randomized Controlled Trials as Topic;  Resistance Training  [methods];  Time Factors;  Walking
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